Proteinuria Management Guidelines
Guideline-Recommended First-Line Therapy
- The Kidney Disease: Improving Global Outcomes (KDIGO) and Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines recommend ACE inhibitors or ARBs uptitrated to maximally tolerated doses as first-line therapy for patients with proteinuria >1 g/day 4
- The American College of Cardiology recommends blood pressure targets of 120-130 mmHg systolic using standardized office measurements 4
- The National Kidney Foundation suggests dietary sodium restriction to <2.0 g/day to enhance antiproteinuric effects 4
- For patients with persistent proteinuria >1 g/day despite 3-6 months of optimized supportive care, a 6-month course of corticosteroid therapy should be considered for conditions like IgA nephropathy, as recommended by the Kidney International and American Journal of Kidney Diseases 2, 3
Evidence-Based Treatment Algorithm for Proteinuria
- The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend initiating ACEi or ARB and uptitrating to maximally tolerated dose, with a target BP <120-130 mmHg systolic 4
- The National Kidney Foundation suggests restricting sodium to <2.0 g/day, normalizing weight, stopping smoking, exercising regularly, and treating metabolic acidosis if bicarbonate <22 mmol/L 4
- For IgA nephropathy, consider a 6-month corticosteroid course if proteinuria >1 g/day persists and eGFR >50 ml/min/1.73 m², as recommended by the Kidney International and American Journal of Kidney Diseases 2, 3
- For membranous nephropathy, consider rituximab or cyclophosphamide with alternating glucocorticoids depending on risk stratification, as recommended by the Kidney International 1, 5
Critical Pitfalls to Avoid
- The Kidney International and American Journal of Kidney Diseases recommend avoiding unproven therapies like sulodexide when evidence-based options (ACEi/ARB, immunosuppression) have demonstrated benefit on hard outcomes 1, 2, 3
- The National Kidney Foundation suggests not stopping ACEi/ARB prematurely with modest creatinine increases up to 30% 4
- The Kidney International and American Journal of Kidney Diseases recommend not delaying immunosuppression in appropriate candidates with persistent proteinuria despite optimal supportive care 2, 3